CEREBROSPINAL FLUID PENETRATION OF PEXIDARTINIB (PLX3397), A CSF1R INHIBITOR, IN A NONHUMAN PRIMATE MODEL

被引：0
|
作者：
Odabas, Arman [1 ]
McCully, Cynthia M. Lester [1 ]
Cruz, Rafael [1 ]
Figg, William D. [1 ]
Glod, John [1 ]
Rymar, Andrey [2 ]
Peer, Cody [1 ]
Warren, Katherine E. [1 ]
机构：
[1] NIH, Bldg 10, Bethesda, MD 20892 USA
[2] Plexxikon Inc, Berkeley, CA USA
来源：
NEURO-ONCOLOGY | 2018年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PHRM-03
引用
收藏
页码：157 / 157
页数：1
相关论文
共 50 条
  • [31] A phase 1b study to assess the safety of PLX3397, a CSF-1 receptor inhibitor, and paclitaxel in patients with advanced solid tumors
    Sharma, Neelesh
    Wesolowski, Robert
    Reebel, Laura
    Rodal, Mary Beth
    Peck, Alexandra
    West, Brian
    Karlin, David Alan
    Dowlati, Afshln
    Le, Mal H.
    Coussens, Lisa M.
    Rugo, Hope S.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [32] PLASMA AND CEREBROSPINAL FLUID (CSF) PHARMACOKINETICS (PK) OF MIRDAMETINIB IN A NONHUMAN PRIMATE (NHP) MODEL
    McCully, Cynthia Lester
    Shearer, Todd
    Gross, Andrea
    Langseth, Abraham
    Peer, Cody
    Killoran, Kristin
    Garcia, Rafael Cruz
    Figg, William, Sr.
    Widemann, Brigitte
    NEURO-ONCOLOGY, 2022, 24 : 233 - 233
  • [33] Early posttraumatic CSF1R inhibition via PLX3397 leads to time- and sex-dependent effects on inflammation and neuronal maintenance after traumatic brain injury in mice
    Wang, Yong
    Wernersbach, Isa
    Strehle, Jenny
    Li, Shuailong
    Appel, Dominik
    Klein, Matthias
    Ritter, Katharina
    Hummel, Regina
    Tegeder, Irmgard
    Schaefer, Michael K. E.
    BRAIN BEHAVIOR AND IMMUNITY, 2022, 106 : 49 - 66
  • [34] PLX3397 treatment inhibits constitutive CSF1R-induced oncogenic ERK signaling, reduces tumor growth, and metastatic burden in osteosarcoma
    Smeester, Branden A.
    Slipek, Nicholas J.
    Pomeroy, Emily J.
    Laoharawee, Kanut
    Osum, Sara H.
    Larsson, Alex T.
    Williams, Kyle B.
    Stratton, Natalie
    Yamamoto, Kenta
    Peterson, Joseph J.
    Rathe, Susan K.
    Mills, Lauren J.
    Hudson, Wendy A.
    Crosby, Margaret R.
    Wang, Minjing
    Rahrmann, Eric P.
    Moriarity, Branden S.
    Largaespada, David A.
    BONE, 2020, 136
  • [35] Early long-term administration of the CSF1R inhibitor PLX3397 ablates microglia and reduces accumulation of intraneuronal amyloid, neuritic plaque deposition and pre-fibrillar oligomers in 5XFAD mouse model of Alzheimer's disease
    Sosna, Justyna
    Philipp, Stephan
    Albay, Ricardo, III
    Reyes-Ruiz, Jorge Mauricio
    Baglietto-Vargas, David
    LaFerla, Frank M.
    Glabe, Charles G.
    MOLECULAR NEURODEGENERATION, 2018, 13
  • [36] Early long-term administration of the CSF1R inhibitor PLX3397 ablates microglia and reduces accumulation of intraneuronal amyloid, neuritic plaque deposition and pre-fibrillar oligomers in 5XFAD mouse model of Alzheimer’s disease
    Justyna Sosna
    Stephan Philipp
    Ricardo Albay
    Jorge Mauricio Reyes-Ruiz
    David Baglietto-Vargas
    Frank M. LaFerla
    Charles G. Glabe
    Molecular Neurodegeneration, 13
  • [37] Significant Sex Differences in the Efficacy of the CSF1R Inhibitor-PLX5622 on Rat Brain Microglia Elimination
    Sharon, Aviv
    Erez, Hadas
    Spira, Micha E.
    PHARMACEUTICALS, 2022, 15 (05)
  • [38] Effect of CSF1R inhibitor on glial cells population and remyelination in the cuprizone model
    Tahmasebi, Fatemeh
    Barati, Shirin
    Kashani, Iraj Ragerdi
    NEUROPEPTIDES, 2021, 89
  • [39] THE CSF PENETRATION OF THE PROCASPASE-ACTIVATING COMPOUND (PAC-1) IN COMBINATION WITH TEMOZOLOMIDE (TMZ) IN A NONHUMAN PRIMATE CSF ACCESS MODEL
    McCully, Cynthia Lester
    Shankarappa, Priya
    Garcia, Rafael Cruz
    Peer, Cody
    Zakharov, Alexander
    Fischer, James
    Lyubimov, Alexander
    Hergenrother, Paul
    Thomas, Marvin
    Figg, William
    Warren, Katherine
    NEURO-ONCOLOGY, 2020, 22 : 92 - 92
  • [40] CSF1R inhibitor PLX5622 and environmental enrichment additively improve metabolic outcomes in middle-aged female mice
    Ali, Seemaab
    Mansour, Anthony G.
    Huang, Wei
    Queen, Nicholas J.
    Mo, Xiaokui
    Anderson, Jacqueline M.
    Hassan, Quais N.
    Patel, Ripal S.
    Wilkins, Ryan K.
    Caligiuri, Michael A.
    Cao, Lei
    AGING-US, 2020, 12 (03): : 2101 - 2122
12345